| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 10/01/2009 | US20090246238 Reinforced absorbable multilayered hemostatic wound dressing |
| 10/01/2009 | US20090246234 Therapeutic Treatment Using Niacin for Skin Disorders |
| 10/01/2009 | US20090246201 Substances |
| 10/01/2009 | US20090246198 Mapk/erk kinase inhibitors and methods of use thereof |
| 10/01/2009 | US20090246181 Therapeutic composition for atopic dermatitis |
| 10/01/2009 | US20090246164 Tissue adhesion |
| 10/01/2009 | US20090246152 Naractin compositions for the inhibition of reactive oxygen species |
| 10/01/2009 | US20090246133 Methods and compositions related to internalizing rgd peptides |
| 10/01/2009 | CA2722618A1 Method of treating degenerative diseases |
| 10/01/2009 | CA2719833A1 Compositions comprising anrnox-inhibitors for the inhibition of reactive oxygen species |
| 10/01/2009 | CA2719769A1 Methods for producing hair microfollicles and de novo papillae and their use for in vitro tests and in vivo implantations |
| 10/01/2009 | CA2719707A1 Therapy for vitiligo |
| 10/01/2009 | CA2719637A1 Methods and compositions for the delivery of agents |
| 10/01/2009 | CA2719256A1 Methods of treating epithelial injury |
| 10/01/2009 | CA2718412A1 Treatment of psoriasis or psoriatic arthritis using cyclopropyl-n-{2-{(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide |
| 10/01/2009 | CA2718296A1 Agent for treating skin aging and scars |
| 09/30/2009 | EP2105499A1 Methods for producing de novo papillae and hair microfollicles and their use for in vitro tests and in vivo implantations |
| 09/30/2009 | EP2105141A1 Short bioactive peptides and methods for their use |
| 09/30/2009 | EP2105139A1 Method of producing a dry earthworm powder |
| 09/30/2009 | EP2105136A2 Pharmaceutical compositions for treating cancer |
| 09/30/2009 | EP2105135A2 Pharmaceutical compositions for treating cancer |
| 09/30/2009 | EP2104533A2 Use of substances reducing cellular glutathione content for producing a medicament for treating t-cell mediated autoimmune diseases |
| 09/30/2009 | EP2104496A2 Use of nepafenac or derivatives thereof for treating dermatological disorders linked with a keratinisation disorder that may include an inflammatory immuno-allergic component |
| 09/30/2009 | EP1555028B1 Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy |
| 09/30/2009 | EP1476130B1 Use of specific diols for reducing the viscosity of cosmetic and/or dermatologic compositions |
| 09/30/2009 | EP1296701B1 Use of grifola frondosa fungus extracts |
| 09/30/2009 | CN101543618A Chinese medicinal composition for treating urticaria and preparation method thereof |
| 09/30/2009 | CN101543600A Acarid killing gel and preparation method thereof |
| 09/30/2009 | CN101543598A Traditional Chinese medicine composition for Gynecological health |
| 09/30/2009 | CN101543586A Medicament for treating phalacrosis and preparation method thereof |
| 09/30/2009 | CN101543581A Speckle-removing oral liquid |
| 09/30/2009 | CN101543577A Traditional Chinese medicine composition for curing whelk and preparation method thereof |
| 09/30/2009 | CN101543570A Smilax glabra total aglycone oral pharmaceutical preparation as well as preparation method and application thereof |
| 09/30/2009 | CN101543565A Chinese medicine external-use preparation medicament for treating surgery wound infection and method for producing the same |
| 09/30/2009 | CN101543555A Combined medicine for treating burn and scald |
| 09/30/2009 | CN101543550A Traditional Chinese medicine liniment for treating white hair |
| 09/30/2009 | CN101543546A Antioxidative substance and composition and use thereof |
| 09/30/2009 | CN101543529A Clinopodium polycephalum total aglycone sustained-release pellet as well as preparation method and application thereof |
| 09/30/2009 | CN101543528A Clinopodium polycephalum total aglycone oral pharmaceutical preparation as well as preparation method and application thereof |
| 09/30/2009 | CN101543525A Beauty composition containing vaccinium vitis-idaea extract and application thereof |
| 09/30/2009 | CN101543512A Method for producing dry earthworm powder |
| 09/30/2009 | CN101543507A Immunostimulatory nucleic acids |
| 09/30/2009 | CN101543503A Partial compound erythrocin zinc acetate gelling agent and preparation method thereof |
| 09/30/2009 | CN101543487A Antipruritic medical composition for infusing hygenic towelette |
| 09/30/2009 | CN101543477A Sustained-release microsphere of chitosan-coated 3,5-dihydroxy-4-isopropyl toluylene and preparation method thereof |
| 09/30/2009 | CN101543469A Skin health care dew |
| 09/30/2009 | CN101543465A Cosmetic composition comprising imidopercarboxylic acid derivative and n-acylated amino acid ester |
| 09/30/2009 | CN100544715C Composition of free-B-ring flavonoids and flavans as a therapeutic agent |
| 09/29/2009 | US7595399 Tyrosine derivatives |
| 09/29/2009 | US7595341 Analogues of lipid mediators derived from ω-3 PUFAs and methods of use |
| 09/29/2009 | US7595321 Useful for the prevention and/or treatment of cognitive disorders; 3-Amino-N-(2-cyanoethyl)-6-[4-(pyrrolidin-1-ylsulfonyl)phenyl]pyrazine-2-carboxamide, for example |
| 09/29/2009 | US7595319 Compounds having selective inhibiting effect at GSK3 |
| 09/29/2009 | US7595301 Staple type oligonucleotide and drug comprising the same |
| 09/29/2009 | US7595052 Composition and method for the prevention and/or the treatment of allergy |
| 09/29/2009 | CA2469350C 3-{4-methyl-3[methyl-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile mono citrate salt |
| 09/29/2009 | CA2434009C Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| 09/29/2009 | CA2403232C 26,27-homologated-20-epi-2-alkyl-19-nor-vitamin d compounds |
| 09/29/2009 | CA2391085C Bis-basic compounds as tryptase inhibitors, processes for preparing them and their use as phamaceutical compositions |
| 09/29/2009 | CA2379560C Purine derivatives inhibitors of tyrosine protein kinase syk |
| 09/29/2009 | CA2376367C Liquid composition for topical application |
| 09/29/2009 | CA2375670C 5-phenyl-pyrimidine derivatives |
| 09/29/2009 | CA2338252C Composition for enhancing lipid production, barrier function, hydrogen peroxide neutralization, and moisturization of the skin |
| 09/29/2009 | CA2318208C Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/29/2009 | CA1341598C Acid-labile sub-unit (als) of insulin-like growth factor binding proteincomplex |
| 09/24/2009 | WO2009117465A1 Substituted gamma lactams as prostaglandin ep2 agonists |
| 09/24/2009 | WO2009117388A1 Therapeutic substituted cyclopentanes |
| 09/24/2009 | WO2009117378A2 Therapeutic amides |
| 09/24/2009 | WO2009116529A1 Polypeptide and pharmaceutical composition containing the polypeptide |
| 09/24/2009 | WO2009116524A1 Modified protein |
| 09/24/2009 | WO2009115707A2 Preparation of hydroquinone amide compounds with antioxidant properties. |
| 09/24/2009 | WO2009115216A1 Use of a component or extract from the baobab plant for skin diseases |
| 09/24/2009 | WO2009115007A1 Use of tat-n25 polypeptide in treating dermatosis relative to abnormal growth of cell and psoriasis |
| 09/24/2009 | WO2009114924A1 Antiseptic compositions for the treatment of infections |
| 09/24/2009 | WO2009085270A3 Use of inhibitors of c0nnexin43 for treatment of fibrotic conditions |
| 09/24/2009 | WO2009068688A3 Composition for treatment and prevention of hair loss and premature graying of hair |
| 09/24/2009 | WO2009065921A3 Novel compounds |
| 09/24/2009 | WO2008030119A9 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
| 09/24/2009 | US20090239952 Vitamin k for prevention and treatment of skin rash secondary to anti-egfr therapy |
| 09/24/2009 | US20090239926 Methods for the treatment of psoriasis or psoriatic arthritis using cyclopropyl-n-carboxamide |
| 09/24/2009 | US20090239885 Inhibitors of nucleoside phoshorylases and nucleosidases |
| 09/24/2009 | US20090239883 Treatment of Pulmonary Hypertension |
| 09/24/2009 | US20090239871 antitumor; breast cancer; 8,9-Dimethoxy-2,3-methylenedioxy-5-[2-(N,N-dimethylamino)ethyl]-5H-dibenzo[c,h]1,6-naphthyridin-6-one |
| 09/24/2009 | US20090239858 Therapeutic amides |
| 09/24/2009 | US20090239839 Receptor antagonist |
| 09/24/2009 | US20090239805 Human 3 relaxin |
| 09/24/2009 | US20090239295 Dedifferentiated, Programmable Stem Cells of Monocytic Origin, and Their Production and Use |
| 09/24/2009 | US20090238905 Inflammation reducing action of synergistic mixtures of bisabolol and ginger extracts |
| 09/24/2009 | US20090238897 Removal of skin changes |
| 09/24/2009 | US20090238892 Deer antler extract for promoting angiogenesis |
| 09/24/2009 | US20090238832 Novel compositions and method for the treatment of psoriasis |
| 09/24/2009 | US20090238823 Antigen binding proteins capable of binding thymic stromal lymphopoietin |
| 09/24/2009 | US20090238809 Application Methods to Rapidly Alter Disease and Injury States Using Molecular Transport of B6 |
| 09/24/2009 | US20090238788 Delivery of hydrogels as sprays |
| 09/24/2009 | US20090238782 Cosmetic composition which includes at least one polysaccharide derived from bacteria of hydrothermal origin |
| 09/24/2009 | US20090238763 High penetration compositions and uses thereof |
| 09/24/2009 | DE102008015428A1 Kühlende Zubereitungen für den humanen Haut- und/oder Schleimhautkontakt mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridin-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexancarboxamid Cooling compositions for the human skin and / or mucous membrane contact with a content of (1R, 2S, 5R) -2-isopropyl-5-methyl-N- (2- (pyridin-2-yl) ethyl-cyclohexanecarboxamide and / or ( 1R, 2S, 5R) -N- (4- (cyanomethyl) phenyl) -2-isopropyl-5-methylcyclohexancarboxamid |
| 09/24/2009 | DE102008015426A1 Kühlende kosmetische oder dermatologische Zubereitungen mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridyn-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexancarboxamid zu Reduktion von Hautrötungen Cooling cosmetic or dermatological preparations with a content of (1R, 2S, 5R) -2-isopropyl-5-methyl-N- (2- (pyridyne-2-yl) ethyl-cyclohexanecarboxamide and / or (1R, 2S, 5R) -N- (4- (cyanomethyl) phenyl) -2-isopropyl-5-methylcyclohexancarboxamid to reduction of skin reddening |
| 09/24/2009 | DE102008015424A1 Kühlende kosmetische oder dermatologische Zubereitungen mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridyn-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5- methylcyclohexancarboxamid mit Menthoxypropandiol Cooling cosmetic or dermatological preparations with a content of (1R, 2S, 5R) -2-isopropyl-5-methyl-N- (2- (pyridyne-2-yl) ethyl-cyclohexanecarboxamide and / or (1R, 2S, 5R) -N- (4- (cyanomethyl) phenyl) -2-isopropyl-5-methylcyclohexancarboxamid with menthoxypropanediol |
| 09/24/2009 | DE102008015299A1 Kolloidales Trägersystem Colloidal carrier system |
| 09/24/2009 | CA2756115A1 Antiseptic compositions for the treatment of infections |